company? Let’s change
that.
Don't see your company?
Create a company profileRCM Brain is a company that helps make the medical billing industry more efficient.
Rau Chocolate building bold and epic chocolate beverages to positively impact the health of people.
Rethinking spine care, one patient at a time.
Cardinal Health is a distributor of pharmaceuticals, a global manufacturer and distributor of medical and laboratory products, and a provider of performance and data solutions for healthcare facilities. With 50 years in business, operations in more than 35 countries and approximately 44,000 employees globally, Cardinal Health is essential to care. We are navigating the complexities of healthcare and providing scaled solutions to help our customers thrive in a changing world. We strive to be a trusted healthcare partner by driving growth in evolving areas of healthcare, while building upon our distribution, products, and solutions to meet customer needs.
COEUS Holdings is a multi-specialty, commercially aligned consultancy, offering a comprehensive suite of informed solutions for successful engagement with organized customers, providers, and patients. COEUS Holdings teams’ strengths harmonize to inform a full spectrum of commercialization efforts, clinical viability, and market success. We strive to maximize commercial market access for biopharmaceutical products and devices. Together, Coeus teams have the collective expertise to inform and shape pricing, reimbursement, contracting, distribution, communication, engagement, launch preparedness, training, and overall brand lifecycle management. Our divisions: COEUS Consulting Market access strategy and commercialization consultancy working to maximize product access throughout its lifecycle. To learn more visit: www.coeusconsultinggroup.com COEUS Healthcare Technology platform designed to aggregate patient data from multiple sources and enable development of real-world evidence beyond claims. To learn more visit: www.coeusconsultinggroup.com MIRADOR Global Consulting expertise in early clinical development for global and domestic drug commercialization and market access efforts. To learn more visit: www.miradorglobal.com COEMIRA Full-service content, creative, and digital agency providing ideation and execution for materials geared toward healthcare decision makers, providers, and patients. To learn more visit: www.coemira.com
We are an analytics-driven, technology-enabled revenue cycle management company that alleviates financial and administrative burdens on healthcare providers by providing billing, coding, automation and analytics services. Our approach is simple: attention to detail and concern for accuracy. Learn more at agshealth.com
We are a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications. Marker’s cell therapy technology is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor associated antigens (i.e. tumor targets) and kill tumor cells expressing those targets. Once infused into patients, this population of T cells attacks multiple tumor targets and acts to activate the patient’s immune system to produce broad spectrum anti-tumor activity. Because Marker does not genetically engineer its T cells, when compared to current engineered CAR-T and TCR-based approaches, its products (i) are significantly less expensive and easier to manufacture, (ii) appear to be markedly less toxic, and (iii) are associated with meaningful clinical benefit. As a result, Marker believes its portfolio of T cell therapies has a compelling therapeutic product profile, as compared to current gene-modified CAR-T and TCR-based therapies. Marker is also advancing a number of innovative peptide- and gene-based immuno-therapeutics for the treatment of cancer and metastatic disease, including our Folate Receptor Alpha program (TPIV200) for breast and ovarian cancers and our HER2/neu+ peptide antigen program (TPIV100/110) in Phase II clinical trials. In parallel, we are developing a proprietary DNA expression technology named PolyStart™ to improve the ability of the cellular immune system to recognize and destroy diseased cells.
Truveris is a leading digital health company focused on delivering truth and clarity in pharmacy. Truveris’ proprietary technology, coupled with deep pharmacy expertise, helps to build a more efficient market that maximizes choice, accessibility and prescription drug affordability. Our solutions provide the insight and knowledge to help people lead healthier and more productive lives.
Vibrent Health’s mission is to accelerate health research to optimize human health through precision technology and digital tools that empower participant engagement, research analytics and research management for researchers, research organizations and research participants. Through its Digital Health Solutions Platform, the company provides a large-scale versatile global platform for health research. The platform provides an infrastructure for data collection from broad sources including genomics, environment, lifestyle, behaviors and electronic health records. Since February 2017 Vibrent Health has served as the Participant Technology Systems Center for the National Institutes of Health’s All of Us Research Program, which aims to collect health data from one million or more people to support a wide variety of research studies.
HeyHerbie is a TV-based platform that connects older adults with their loved ones and helps them stay active and vibrant in their own homes.
Tonal is the most powerful way to be, look, and feel your strongest. Unlike traditional dumbbells and barbells, Tonal uses advanced digital weight that continually adapts workouts so they’re most effective for you—all led by our expert coaches. No matter if you’re a beginner or an expert, you’ll #BeYourStrongest with Tonal. www.tonal.com/careers All official Tonal career communication will come from a @tonal.com email address. If you are ever uncertain of whether a solicitation is from Tonal or an approved recruiting partner of ours, please reach out to [email protected].
RuckPack is a provider of a caffeine-free, two-ounce, blood orange energy drink.
Kinship is here to help everyone pet parent like a pro. Why? Because our pets make us better humans, and we owe them the best possible care. As the premier partner to a new generation of pet parents, we use our data, products, and services to help people be the best pet parents they can be. And we unite changemakers in pet care to break down barriers, open new doors, share insights, and advance our collective knowledge. All so we can reimagine the pet parenting experience, up people’s confidence, and help the world find better ways to care. Kinship is a coalition that includes: Adopt-a-Pet, the destination for finding homes for homeless pets The Wildest, the destination that helps pet parents keep their cool in the wild world of pet parenting The Kin, our mobile application that houses everything a pet parent needs to care for their pet and live their best lives together. The app brings together the three Kinship consumer brands and matches pet needs to quality service providers, helps them book and share necessary records, and provides personalized content so pet parents can parent with ease and confidence. PetExec, a B2B (SaaS) digital operations manager and the world's leading tool for petcare businesses. Together, these teams and more work to set new standards in pet care. And, as a part of Mars Petcare, they work to create a better world for pets. Learn more at www.kinship.co.
Medicat is an electronic health record system.
A Cleveland-based pharmacy focused on improving medication adherence for patients with chronic conditions and on multiple medications
Since 2008 TDBBS has been proud to offer the widest selection of high-quality natural dog treats and chews available.
Guardion Health Sciences is dedicated to applying a scientific discipline and pharmaceutical approach to the development of safe.
We work to improve the well-being of individuals and families by delivering quality, comprehensive physical and behavioral healthcare services. We coordinate services for the needs of all who seek care, regardless of socioeconomic status. We partner for creative solutions to meet the diverse needs of individuals, families and communities.
Glycan Therapeutics develops drug therapies based on a novel synthetic carbohydrate technology platform.
Sorrento Therapeutics, Inc. is a clinical stage and commercial biopharmaceutical company focused on delivering innovative and clinically meaningful therapies to address unmet medical needs. Our vision is to leverage our proprietary G-MAB™ library in conjunction with a proprietary targeted delivery modalities to generate the next generation of therapeutics for treating cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. These modalities include proprietary chimeric antigen receptor T-cell therapy (CAR-T), dimeric antigen receptor T-cell therapy (DAR-T™), antibody-drug conjugates (ADCs), oncolytic virus (Seprehvec™), lymphatic drug targeting (SOFUSA®), as well as bispecific antibody approaches. We are additionally developing pain management solutions, including our clinical candidates resiniferatoxin (RTX) and SEMDEXA™. In response to the global SARS-CoV-2 (“COVID-19”) pandemic, we are also developing and conducting clinical studies for potential coronavirus antiviral therapies and vaccines, including Abivertinib, COVI-MSC™, COVI-AMG™, COVIDROPS™, and COVI SHIELD™, and diagnostic test solutions, such as COVISTIX™ and COVITRACK™.